Forte Biosciences, Inc. — Director's Dealing 2021

Jan 14, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Forte Biosciences, Inc. (FBRX)
CIK: 0001419041
Period of Report: 2021-01-13

Reporting Person: DARCY THOMAS E (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-13	Common Stock	M	500	$9.5865	Acquired	2358	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-13	Stock Option (right to buy)	$9.5865	M	500	Disposed	2021-06-15	Common Stock (500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	24637	Indirect

Footnotes

F1: The shares vest in a series of twelve (12) successive equal monthly installments measured from October 3, 2019. The option originally covered 7,500 shares pre 15-to-1 reverse stock split which became effective on June 15, 2020.

F2: The Form 4 filed October 4, 2019 incorrectly reported the Expiration Date as October 3, 2029. The correct Expiration Date is June 15, 2021.